New drug may help rare fat disorder patients control diabetes
NCT ID NCT07091734
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 22 times
Summary
This study tests whether tirzepatide, a diabetes drug, can improve blood sugar and lower triglycerides in people with partial lipodystrophy, a rare condition causing abnormal fat loss. About 32 adults with poor diabetes control and high triglycerides will receive the drug or serve as a control for 24 weeks. The goal is to see if reducing calorie intake through the drug leads to better metabolic health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPODYSTROPHY, PARTIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.